Endurance is a knowledge-based, relationship-driven strategic advisory firm focusing on investor relations and capital markets. We serve as thought-partners for innovative biopharmaceutical companies.


Endurance was founded in 2018 and has offices in San Francisco and New York.

About Endurance

Experience

  

Our focused team brings over 40 collective years of experience partnering with 75+ biopharmaceutical companies across therapeutic areas and all stages of development.


We have helped management teams navigate dozens of pivotal trials, regulatory interactions, and business development transactions, including multiple drug launches. 


Endurance’s capital markets expertise spans private financings, IPOs and follow-on offerings, including more than 100 successful financings over $10bn in capital raised.

Capabilities


Biopharmaceutical companies value IR counsel as one component of the broader strategic plan. Endurance’s strategic advisory expertise brings a trusted perspective that permeates a multitude of corporate development functions.


Investor Relations 

Our core expertise is executing the investor relations function for biopharmaceutical companies. At Endurance, we develop and implement IR programs with the goal of increasing visibility, access and awareness within the investment community. 


  • Investor Relationships and Engagement
  • Best Practice Implementation
  • Positioning and Messaging
  • Competitive Intelligence
  • Scenario Planning


Capital Markets Advisory 

A successful IR program positions companies to access the capital markets. Endurance’s capital markets expertise empowers management teams throughout the financing process by providing an independent, unbiased perspective. 

  • Private financings, IPOs & Follow-Ons
  • Process implementation

The Endurance Team

Michael Zanoni

Michael Zanoni

Michael Zanoni

Managing Partner & Co-Founder

Chad Rubin

Michael Zanoni

Michael Zanoni

Managing Partner

Peter Rahmer

Michael Zanoni

Peter Rahmer

Senior Advisor & Co-Founder

Biopharma Investor Relations and Capital Markets

Contact: info@enduranceadvisors.com